Cardinal health q1 non-gaap earnings per share $1.27

Cardinal health reports first quarter results for fiscal year 2020.reaffirms fy 2020 non-gaap earnings per share view $4.85 to $5.10.q1 non-gaap earnings per share $1.27.q1 gaap loss per share $16.65.q1 revenue $37.3 billion versus refinitiv ibes estimate of $36.75 billion.q1 earnings per share estimate $1.09 -- refinitiv ibes data.q1 revenue for pharmaceutical segment increased 6 percent to $33.4 billion.cardinal health - co reaffirms its fiscal year 2020 guidance range for non-gaap diluted eps attributable to cardinal health, inc. of $4.85 to $5.10.global opioid lawsuit settlement framework includes agreement in principle by co to pay up to $5.56 billion over 18 years.company also agreed to a $66 million settlement with two ohio counties.sees capital expendiatures for fy2020 $320 million- $360 million.cardinal health - in connection with opioid lawsuits settlement, co accrued $5.63 billion ($5.14 billion after tax) excluded from qtrly non-gaap earnings.
CAH Ratings Summary
CAH Quant Ranking